Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/5/2010

pyretic effects of OFIRMEV may mask fever in patients treated for post-surgical pain.

About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com.

Forward-Looking Statements Statements included in this press release and the conference call that are not a description of historical facts are forward-looking statements. Words such as "plans," "believes," "expects," "anticipates," and "will," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Forward-looking statements include, but are not limited to, statements regarding: the readiness of Cadence for and the timing of the planned commercial launch of OFIRMEV; the market potential for OFIRMEV; OFIRMEV's ability to fulfill unmet medical needs in the treatment of pain and fever in the hospital setting; the sufficiency of the company's capital resources to fund its operations through the launch of OFIRMEV; and all of the company's financial estimates or projections. Actual results may differ materially from those set forth in this press release and the conference call due to the risks and uncertainties inherent in the company's business, including, without limitation: our dependence on the successful commercialization of OFIRMEV; the potential that we will require substantial additional funding in order to effectively commercialize OFIRMEV, and the risk that we may not be able to raise sufficient capital when needed, or at all; the risk that delays in commercially launching OFIRMEV would enable competitors to further entrench their existing products or develop and bring new products to market before OFIRMEV; our ability to ensure an adequate
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mass. , July 28, 2015  Insulet Corporation ... pump technology with its OmniPod ® Insulin Management ... has been appointed to Insulet,s Board of Directors. ... top-tier healthcare experience to the Insulet Board. She currently ... the Joslin Diabetes Center, the world,s largest diabetes research ...
(Date:7/28/2015)... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) ... financial results after the market closes on Tuesday, August ... will be held on Tuesday, August 4, 2015, at ... To participate in the call, please dial 877-303-1298 ... rebroadcast of the teleconference will be available for one ...
(Date:7/28/2015)... /PRNewswire-USNewswire/ -- Kentucky,s ... after a 2012 law required providers to check a ... yet more evidence that Californians need the same protections, ... Kentucky,s prescription drug abuse legislation took ... 52 percent; opioid prescriptions to doctor-shopping individuals dropped by ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Cumberland Pharmaceuticals To Announce Second Quarter 2015 Financial Results 2Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2
... LEUVEN, Belgium, September 29 , - Results ... ThromboGenics NV (Euronext Brussels: THR), a biotechnology company,focused ... and cancer,announces positive results from its MITI IV ... efficacy of microplasmin when administered,intravenously to acute stroke ...
... Dikembe Mutombo Foundation to improve healthcare,system in the ... Sept. 25 The Clinton Global,Initiative recognized BD ... a,leading global medical technology company, for its commitment ... system monitoring and,healthcare worker safety at the Biamba ...
Cached Medicine Technology:ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 2ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 3ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 4Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, a vertically ... invention that makes shelling eggs an exact science. , “The global kitchen appliances ... and Creative Director of World Patent Marketing. “With a growth rate of 6.4%, ...
(Date:7/28/2015)... ... , ... The Denver Foundation and Blair-Caldwell African American Research ... photographic and narrative exploration of African American giving, which runs August 1-31 at ... is one of only ten cities to host “The Soul of Philanthropy Reframed ...
(Date:7/28/2015)... ... 28, 2015 , ... Autism is the fastest growing serious ... with the disorder. For these families, identifying and paying for the help they ... That’s where Talk About Curing Autism (TACA), a national non-profit organization dedicated to ...
(Date:7/28/2015)... ... July 16, 2015 (PRWEB) July 28, 2015 , ... Nations ... Health insurance quotes to its clients, recently announced the launch of Commercial, Auto ... suits their specific needs. , Liability automobile insurance policies are one popular ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... Dr. ... diseases. , The talk took place from noon to 1 p.m. Tuesday, June 23, ... Panama City, Fla. , Dr. Ahmad is board-certified in colorectal surgery and has ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... on findings of a recent study researchers say Lipid-lowering drugs ... // or at a follow-up appointment with a doctor. ... is started during a hospital stay vs. in an outpatient ... the United States and Canada were involved in the study, ...
... known scientist and accomplished businessman of the U.S. holding ... to set up a high end rapid //diagnostic centre ... be a marketing, selling and research company. ... BioAsia 2004 conference Bangalore on February 28, he said ...
... and benefits of using CT scanning for young children ... than 3,000 men who received radiation therapy before 18 ... at age 18 years or 19 years. Researchers also ... ,Results of the study showed boys who received increasing ...
... study assessing the use of hormone replacement therapy among breast ... an unacceptably high rate of recurring or new cancers. ... women are surviving the disease and therefore subject to the ... to involve around 1,300 women over five years. After the ...
... of osteoporosis. Such a break can lead to acute and ... to a recent study , it was found that the ... effective in reducing the risk for a vertebral fracture, according ... can reduce the risk of breaking a bone in the ...
... technology may help people suffering from paralysis reprogram their ... to findings of a recent study . ,Functional ... during motor activities and allow patients to redirect motor ... taking over for the damaged ones. But until now, ...
Cached Medicine News:
Inquire...
... Menopause Predictor Test is a qualitative, ... of Follicle Stimulating Hormone (FSH) in ... hormone changes related to the symptoms ... The FHS Menopause Predictor Test ...
... The ACONO H. pylori Rapid Test Strip ... the qualitative detection of antibodies to Helicobacter ... or plasma to aid in the diagnosis ... years of age and older. They are ...
... The Trinity Biotech Uni-Gold™ H. pylori ... in vitro qualitative detection of IgG ... in adult human serum, plasma or ... the diagnosis of H. pylori infection ...
Medicine Products: